Abstract
During treatment with azithromycin, a 55 year-old woman developed a newly prolonged QT interval and torsade de pointes in the absence of known risk factors. Female gender and acute renal failure may be considerations in patients treated with azithromycin.
Article PDF
Avoid common mistakes on your manuscript.
References
Haverkamp, W., Breithardt, G. R., Camm, A. J., Janse, M. J., Rosen, M. R., Antzelevitch, C., et al. (2000). The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications. Cardiovascular Research, 47, 219–233.
Moss, A. J, Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J., et al. (1991). The long QT syndrome. Prospective longitudinal study of 328 families. Circulation, 84, 1136–1144.
Brandriss, M. W., Richardson, W. S., & Barold, S. S. (1994). Erythromycin-induced QT prolongation and polymorphic tachycardia (torsades de pointes): Case report and review. Clinical Infectious Diseases, 18, 995–998.
Lee, K. L., Jim, M. H., Tang, S. C., & Tai, Y. T. (1998). QT prolongation and Torsades de Pointes associated with clarithromycin. American Journal of Medicine, 104, 395–396.
Rubinstein, E. (2001). Comparative safety of the different macrolides. International Journal of Antimicrobial Agents, 18(Suppl 1), 71–76.
Samarendra, P., Kumari, S., Evans, S. J., Sacchi, T. J., & Navaro, V. (2001). QT Prolongation Associated with Azithromycin/Amiodarone combination. PACE, 24, 1572–1574.
Arellano-Rodrigo, E., Garcia, A., Mont, L., & Roque, M. (2001). Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome. Medical Clinic (Barc), 117, 118–119.
Matsunaga, N., Oki, Y., & Prigollini, A. (2003). A case of QT interval prolongation precipitated by azithromycin. New Zealand Medical Journal, 1, 1185–1186.
Strle, F., & Maraspin, V. (2002). Is azithromycin treatment associated with prolongation of the Q-Tc interval? Wien Klin Wochenschr, 114, 396–399.
Kim, M. H., Berkowitz, C., & Trohman, R. G. (2005). Polymorphic ventricular tachycardia with a normal QT interval following azithromycin. PACE, 28, 1221–1222.
Milberg, P., Eckardt, L., Bruns, H. J., Biertz, J., Ramtin, S., Reinsch, N., et al. (2002). Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. Journal of Pharmacology and Experimental Therapeutics, 303, 218–225.
Eckardt, L., Breithardt, G., & Haverkamp, W. (2002). Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: Low torsadogenic potential despite QT-prolongation. Journal of Pharmacology and Experimental Therapeutics, 300, 64–71.
Höffler, D., Paeske, B., & Koeppe, P. (1995). Pharmacokinetics of azithromycin in normal and impaired renal function. Infection, 23, 356–361.
Bonnar, C. E., Davie, A. P., Caruana, L., Fenn, L., Ogston, S. A., McMurray, J. J. V., et al. (1999). QT dispersion in patients with chronic heart failure: β Blockers are associated with a reduction in QT dispersion. Heart, 81, 297–302.
Ex Card Research http://www.qtdrugs.com
Drici, M. D., Knollmann, B. C., Wang, W. X., & Woosley, R. L. (1998). Cardiac actions of erythromycin: Influence of female sex. Journal of the American Medical Association, 280, 1774–1776.
Makkar, R. R., Fromm, B. S., Steinman, R. T., Meissner, M. D., & Lehmann, M. H. (1993). Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. Journal of the American Medical Association, 270, 2590–2597.
Lorincz, I., Matyus, J., Zilahi, Z., Kun, C., Karanyi, Z., & Kakuk, G. (1999). QT dispersion in patients with end-stage renal failure and during hemodialysis. Journal of the American Medical Association, 10, 1297–1302.
Ozdemir, D., Mese, T., Agin, H., Calkavur, S., & Bak, M. (2005). Impact of haemodialysis on ATc dispersion in children. Nephrology, 10, 119–122.
Sarlagadda, S., & Perazella, M. (2006). Acute renal failure in the hospital: Diagnosis and management. Hospital Physician, 51–58.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kezerashvili, A., Khattak, H., Barsky, A. et al. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors. J Interv Card Electrophysiol 18, 243–246 (2007). https://doi.org/10.1007/s10840-007-9124-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-007-9124-y